3888 related articles for article (PubMed ID: 6402551)
1. Characterization of structural properties for morphologic differentiation of melanosomes. III. free and protein-bound dopa and 5-S-cysteinyldopa in B16 and Harding-Passey melanomas.
Ito S; Homma K; Kiyota M; Fujita K; Jimbow K
J Invest Dermatol; 1983 Mar; 80(3):207-9. PubMed ID: 6402551
[TBL] [Abstract][Full Text] [Related]
2. Expression of basic fibroblast growth factor in desmoplastic melanoma.
al-Alousi S; Carlson JA; Blessing K; Cook M; Karaoli T; Barnhill RL
J Cutan Pathol; 1996 Apr; 23(2):118-25. PubMed ID: 8721445
[TBL] [Abstract][Full Text] [Related]
3. [Isolation and study of the antibiotics produced by a culture of Str. iverini (Gause et al., 1957) Pridham et al., 1958].
Frolova VI; Kuzovkov AD; Katrukha GS; Rozynov BV; Trifonova ZhP
Antibiotiki; 1984 Jan; 29(1):7-14. PubMed ID: 6696407
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of 111In-octreotide scans in CNS tumors.
Sciuto R; Ferraironi A; Semprebene A; Occhipinti E; Mastrostefano R; Crecco M; Mottolese M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):101-3. PubMed ID: 9002762
[TBL] [Abstract][Full Text] [Related]
5. Metastases in malignant melanoma.
O'Rourke MG; Louie A
Aust N Z J Surg; 1982 Apr; 52(2):154-8. PubMed ID: 6952857
[TBL] [Abstract][Full Text] [Related]
6. Systemic or regional chemotherapy: does it matter and should surgeons be involved?
Stephens FO
J R Coll Surg Edinb; 1998 Apr; 43(2):80-1. PubMed ID: 9621525
[TBL] [Abstract][Full Text] [Related]
7. UV-induced N-ras mutations are T-cell targets in human melanoma.
van Elsas A; Scheibenbogen C; van der Minne C; Zerp SF; Keilholz U; Schrier PI
Melanoma Res; 1997 Aug; 7 Suppl 2():S107-13. PubMed ID: 9578425
[TBL] [Abstract][Full Text] [Related]
8. Tumors in the posterior pole.
Edwards MG; Schachat AP
Int Ophthalmol Clin; 1995; 35(4):123-35. PubMed ID: 8847188
[No Abstract] [Full Text] [Related]
9. [A novel antitumor agent, sobuzoxane (MST-16)].
Tsukagoshi S
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1089-97. PubMed ID: 8002628
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
11. Cytodiagnosis of malignant melanoma of soft tissue: report of a case with diagnosis by intraoperative cytology.
Ishi K; Suzuki F; Saito A; Koyatsu J; Kina K; Shitoto K
Acta Cytol; 1998; 42(5):1177-80. PubMed ID: 9755678
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cultured cells derived from Mongolian gerbil's (Meriones unguiculatus) ascitic malignant melanoma.
Hashimoto O; Miyamoto K; Moritomo T; Saito H; Watanabe T; Mochizuki K
J Vet Med Sci; 1993 Apr; 55(2):227-32. PubMed ID: 8513002
[TBL] [Abstract][Full Text] [Related]
13. Gamma-probe-guided lymph node localization in malignant melanoma.
Alex JC; Weaver DL; Fairbank JT; Rankin BS; Krag DN
Surg Oncol; 1993 Oct; 2(5):303-8. PubMed ID: 8305972
[TBL] [Abstract][Full Text] [Related]
14. Intracellular localization and biochemical function of variant beta-actin, which inhibits metastasis of B16 melanoma.
Sadano H; Shimokawa-Kuroki R; Taniguchi S
Jpn J Cancer Res; 1994 Jul; 85(7):735-43. PubMed ID: 8071115
[TBL] [Abstract][Full Text] [Related]
15. [Biokinetics of tumor-affinity yttrium preparations--Part 1].
Schomäker K; Hientzsch B; Franke WG; Scheidhauer K; Scharl A; Jantsch K; Shukla SK; Limouris G; Schicha H
Nuklearmedizin; 1995 Feb; 34(1):32-9. PubMed ID: 7724362
[TBL] [Abstract][Full Text] [Related]
16. [Non-urothelial tumors of the urinary tract].
Mikuz G
Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
[TBL] [Abstract][Full Text] [Related]
17. [Thermochemotherapy for malignant melanoma--combination therapy of ACNU and hyperthermia in mice].
Yamada K; Someya T; Shimada S; Ohara K; Kukita A
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2179-87. PubMed ID: 6578704
[TBL] [Abstract][Full Text] [Related]
18. Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFN-gamma, or combination IL-2 + IFN-gamma.
Kircheis R; Küpcü Z; Wallner G; Wagner E
Cytokines Cell Mol Ther; 1998 Jun; 4(2):95-103. PubMed ID: 9681248
[TBL] [Abstract][Full Text] [Related]
19. Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100.
Schreurs MW; de Boer AJ; Schmidt A; Figdor CG; Adema GJ
Melanoma Res; 1997 Dec; 7(6):463-70. PubMed ID: 9464618
[TBL] [Abstract][Full Text] [Related]
20. Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
Anticancer Res; 1996; 16(5A):2581-7. PubMed ID: 8917355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
